Profile change history

What changed for Thymosin alpha-1?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Thymosin alpha-1 identity.

48Total events
48Record additions
0Version changes
15Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 48 connected records →

Showing the latest 48 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00001036

PeptideScanner retained ClinicalTrials.gov record NCT00001036 at 2026-11-15T22:10:40.222Z. Its registry update date was 2008-07-30, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
July 30, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00711620

PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
June 14, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00911443

PeptideScanner retained ClinicalTrials.gov record NCT00911443 at 2026-11-15T22:10:40.222Z. Its registry update date was 2009-07-09, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
July 9, 2009
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01031966

PeptideScanner retained ClinicalTrials.gov record NCT01031966 at 2026-11-15T22:10:40.222Z. Its registry update date was 2012-03-29, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
March 29, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01178996

PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
August 10, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02473406

PeptideScanner retained ClinicalTrials.gov record NCT02473406 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-04-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 5, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02646189

PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
January 5, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02867267

PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 10, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02883595

PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 4, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03659578

PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
January 3, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04428008

PeptideScanner retained ClinicalTrials.gov record NCT04428008 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 21, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05086614

PeptideScanner retained ClinicalTrials.gov record NCT05086614 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-10-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
October 21, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06024356

PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
June 18, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06139419

PeptideScanner retained ClinicalTrials.gov record NCT06139419 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
August 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06461910

PeptideScanner retained ClinicalTrials.gov record NCT06461910 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-03-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
March 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07780721

PeptideScanner retained ClinicalTrials.gov record NCT07780721 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
August 21, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07884201

PeptideScanner retained ClinicalTrials.gov record NCT07884201 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
October 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07922954

PeptideScanner retained ClinicalTrials.gov record NCT07922954 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
November 6, 2026
Evidence lane
Clinical trials
Record added

Thymosin alpha-1.

PubMed lists PMID 11381492 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, Review, with publication-date metadata of 2001-05-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 22, 2019
Evidence lane
Literature metadata
Record added

Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

PubMed lists PMID 12860169 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2003-08 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Thymalfasin for the treatment of chronic hepatitis B.

PubMed lists PMID 15482167 in Expert review of anti-infective therapy as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2019
Evidence lane
Literature metadata
Record added

Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.

PubMed lists PMID 15546255 in Journal of gastroenterology and hepatology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.

PubMed lists PMID 15641208 in Journal of gastroenterology and hepatology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.

PubMed lists PMID 15641209 in Journal of gastroenterology and hepatology as Clinical Trial, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Thymalfasin for the treatment of chronic hepatitis C infection.

PubMed lists PMID 16307501 in Expert review of anti-infective therapy as Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2018
Evidence lane
Literature metadata
Record added

Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.

PubMed lists PMID 17600281 in Annals of the New York Academy of Sciences as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.

PubMed lists PMID 18410608 in Journal of gastroenterology and hepatology as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.

PubMed lists PMID 19033321 in Journal of intensive care medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-11-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

From lab to bedside: emerging clinical applications of thymosin alpha 1.

PubMed lists PMID 19392576 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 16, 2022
Evidence lane
Literature metadata
Record added

Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.

PubMed lists PMID 19467157 in Virology journal as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 16, 2024
Evidence lane
Literature metadata
Record added

Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.

PubMed lists PMID 20194853 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 28, 2025
Evidence lane
Literature metadata
Record added

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

PubMed lists PMID 20536445 in Annals of the New York Academy of Sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Thymosin alpha 1: past clinical experience and future promise.

PubMed lists PMID 20536460 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.

PubMed lists PMID 20536461 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Thymalfasin in the treatment of hepatitis B and C.

PubMed lists PMID 20536462 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

[Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].

PubMed lists PMID 21272455 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology as Journal Article, Meta-Analysis, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.

PubMed lists PMID 22010537 in Journal of preventive medicine and hygiene as Journal Article, Review, with publication-date metadata of 2011-09 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

PubMed lists PMID 22233415 in Journal of viral hepatitis as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2012-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Thymosin alpha 1 and HIV-1: recent advances and future perspectives.

PubMed lists PMID 28106477 in Future microbiology as Journal Article, Review, with publication-date metadata of 2017-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.

PubMed lists PMID 30063860 in Expert opinion on biological therapy as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 11, 2019
Evidence lane
Literature metadata
Record added

Serum thymosin alpha 1 levels in normal and pathological conditions.

PubMed lists PMID 30063864 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 25, 2019
Evidence lane
Literature metadata
Record added

Thymosin alpha 1 treatment for patients with sepsis.

PubMed lists PMID 30063866 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 25, 2019
Evidence lane
Literature metadata
Record added

Thymosin alpha 1: A comprehensive review of the literature.

PubMed lists PMID 33362999 in World journal of virology as Journal Article, Review, with publication-date metadata of 2020-12-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 29, 2020
Evidence lane
Literature metadata
Record added

Phenotypic drug discovery: a case for thymosin alpha-1.

PubMed lists PMID 38903817 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2024-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 22, 2024
Evidence lane
Literature metadata
Record added

Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

PubMed lists PMID 39648386 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2024-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 16, 2024
Evidence lane
Literature metadata
Record added

Aging and Thymosin Alpha-1.

PubMed lists PMID 41373628 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-11-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 14, 2025
Evidence lane
Literature metadata
Record added

Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.

PubMed lists PMID 41749205 in BMC medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 14, 2026
Evidence lane
Literature metadata
Record added

Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.

PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 29, 2026
Evidence lane
Literature metadata